Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs

April 6, 1998

Orally active thrombin inhibitor discovered at Pfizer shows good tolerance in phase I

April 6, 1998

Amidino derivatives for thrombosis reported by Astra

April 6, 1998

ART-123, a human recombinant thrombomodulin, demonstrates acceptable safety profile

April 6, 1998

FDA says Integrilin is approvable

April 3, 1998

Mechanism of vasorelaxant effects of HFV-1017C elucidated

April 2, 1998

Banyu develops factor Xa inhibitors as antiplatelet/antithrombotic agents

April 2, 1998

Preliminary results of TIMI 15A trial reported at ACC

April 1, 1998

Anticoagulants in development at DuPont Merck

April 1, 1998

Potent and selective PDE III inhibitor in development at Otsuka

March 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...